MYD88 and liver disorder: Illustrating the importance of innate immunity, mice deficient in key mediators of LPS signalling such as TLR4, CD14 and MyD88 display better outcomes during liver disease.4 31 32 Here, we tested a hypothesised anti-inflammatory role for TREM-2 in liver disease.